Fibrodysplasia ossificans p r o g r d v a (FOP) is a catastrophic genetic disorder of progressive heterotopic ossification associated with dysregulated production of bone morphogenetic protein 4 (BMP4), a potent osteogenic morphogen. Postnatal heterotopic ossification in FOP is often heralded by hectic episodes of severe postmumatic connective tissue. swelling and intramuscular edema, followed by an intense and highly angiogenic fibroproliferative mass. The abrupt appearance, intense sue, and rapid intrafascial spread of the edematous preosseow fibroproliferative lesions implicate a dysregulated wound response mechanism and suggest that cells and mediators involved in inflammation and tissue repair may be con- 
Fibrodysplasia ossificans p r o g r d v a (FOP) is a catastrophic genetic disorder of progressive heterotopic ossification associated with dysregulated production of bone morphogenetic protein 4 (BMP4), a potent osteogenic morphogen. Postnatal heterotopic ossification in FOP is often heralded by hectic episodes of severe postmumatic connective tissue. swelling and intramuscular edema, followed by an intense and highly angiogenic fibroproliferative mass. The abrupt appearance, intense sue, and rapid intrafascial spread of the edematous preosseow fibroproliferative lesions implicate a dysregulated wound response mechanism and suggest that cells and mediators involved in inflammation and tissue repair may be conscripted in the growth and progression of FOP lesions. The central and coordinate role of inflammatory mast cells and their mediators in tissue edema, wound repair, fibrogenesis, angiogenesis, and tumor invasion prompted us to investigate the potential involvement of mast cells in the pathology of FOP lesions. We show that inflammatory mast cells are present at every stage of the development of FOP Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized bv , congenital malformatioll of the great toes and by progressive heterotopic ossification in defined anatomic pattenls.1" Spontaneous and post-traumatic flare-ups of FOP are heralded bv e~isodes of intense connective , L tissue edema with early histologic evidence of perivascular lynlphocytic infiltration into skeletal muscle."" Highly ailgiogenic fibroproliferative lesions appear within hours, spread rapidly along muscle planes, and evolve through an endochondral ossification process to form mature lamellar b~ne.*.~.S Heterotopic ossification in FOP leads to immobilization of joints in the axial and appendicular skeleton, rendering movement impos~ible.',:~,"JO Death frequently results from starvation due to ankylosis of the jaw or from complications of severe restrictive disease of the chest wa11.2.".11." Presently, there is no effective prevention or treatme11t.l:~ Although the genetic basis and pathophysiology of FOP are unknown, recent studies show overproduction of bone morphogenetic protein 4 (BMP4) in lesional lymphocytes, lesional proliferating fibroblasts, and lyrnphoblastoid cell lines from patients with FOP.rJ*17 Additionally, elevated levels of urinary basic fibroblast growth factor (bFGF), a potent angiogenic peptide, are noted during FOP flare-ups but not during disease quiescence.lR However, bFGF is not overproduced in lesional proliferating fibroblasts, implicating other cells as the source of bFGF. The intense soft tissue swelling and rapidly progressive muscle edema, fibroproliferation, and angiogenesis characteristic of earlv preosseous FOP lesioils suggests involvement of an armada of inflammatory mediators at the leading edge of the lesion and points to a poteiltial role for inflammato~y mast cells in the spread of the disease process.
Mast cells mediate i~lfla~nmato~y reactions that are widely distributed in connective tissues. Mast cells arise from C~3 4 ' pluripotent stem cells of heinatopoietic origin, circulate through the blood as committed but undifferentiated cells, and migrate into nuinerous tissues iilcluding skeletal muscle, where they matiire in the PI-esence of c-kit-ligand (stem cell factor). blast cells are indigenous to connective tissues ancl are found in close proxiinity to blood \*essels and nerves." 111 ~lornlal skeletal muscle, mast cells are found sparsely distributed in the connectire tissue interstitium that 1101-mally demarcates the fascicular structure of the mwcle tiss~e.~!'.'~ T h e cytoplasm of inflainmatol-y mast cells contains promillent metachronlatic gi-allules whose sequestered contents include histamine, heparin, proangiogeilic peptides, and extracellular matiix-degrading proteinases, including nletalloproteinases, serine proteinases, chymases, acid hydrolases, and ~athepsins.".'5~26.3~~~2 Little is known about the resident mast cell population in skeletal muscle. We have undertaken a comprehensive analysis of mast cell distribution in normal skeletal muscle, in uninvoh~ed skeletal muscle from patients with FOP, in FOP lesions, and in inflammatory myopathies to determine if mast cells may be involved in the pathology of FOP lesions.
MATERIALS AND METHODS

Patient Population
Between 1988 and 1999,174 patients with classic features of FOP were referred to the FOP clinic at the University of Pennsylvania School of Medicine and were seen at the Children's Hospital of Philadelphia, at the Hospital of the Unil'ersity of Pennsylvania, or at one of the satellite clinics conducted by 2 of us (F.S.K and D.L.G.). Adefinitive diagnosis of FOP was confirmed in all 174 patients on the basis of congenital malformation of the great toes and progressive heterotopic ossification in characteristic anatomic patterns. FOP protocols were approved by the institutional review boards of the Children's Hospital of Philadelphia and the University of Pennsylvania, and informed consent was obtained from all patients or their parents.
FOP Biopsy Specimen Retrieval
All FOP lesional tissue jcas retrieved from the tissue repository at the Center For Research in FOP and Related Disorders at The University of Pennsylvania. Tissue blocks were originally procured after patient or parental permission b* obtained. All lesional samples contained in the database jvere used. At the time of the stud:, paraffin-embedded tissue blocks of FOP lesions were available from 7 of the 1'74 classically affected FOP patients. Multiple blocks of the lesions were available for 3 of the 7 patients (3 girls and 3 boys), who ranged in age from 1 to 10 years at the time of the biopsies. Samples were obtained from fibrous tissue in deep fascia and from paravertebral, infraspinatus, frontalis, sternocleidomastoid, ~~astils lateralis, and intercostal muscles. All specimens had been resected by meal~s of an open biopsy of lesional tissue. The FOP lesional biopsies had been pelformed a1 other medical centers to exclude the diagnosis of a soft tissue neoplasm, and in none of the cases was the correct diagnosis suspected before surgery. FOP nonlesional muscle tissue was obtained from 3 children with FOP who underwent emerge~lcy surgical procedures for intel-current PI-oblems.
Inflammatory Muscle Conditions
Specimens from normal contl-01 mttscle tissue and genetic and nonparasitic inflammatory myopathies were retrieved from the files of the Armed Forces Institute of Pathology during the period of 1996 through 1998. One hundred six cases were included in the analysis and involved a variety of muscle groups (quadraceps, deltoid, mandible, omohyoid, biceps, trapezius, sternocleidomastoid, gastrocnemiits, scalenus, rectus, vastus lateralis, tibialis anterior, and diaphragm) and the following conditions: minimal inflammati~n?~ severe inflammatoq myopathy,l5 polymyositis,~e~~naton~yositis,~ acute infection,%car,2 tumor invading into muscle,2 foreign body,' infarct,' and pan necrosis.' A total of 62 men and 44 women ranging in age from 1 to 78 years were represented in this series.
Ti ssue Specimens and Histopathologic Evaluations
All tissue specimens had been fixed in neutral buffered formalin and embedded in paraffin. Specimens were sectioned at a thickness of 5 /LIII and stained with hematoxylineosin, toluidine blue, Giemsa, and cllloracetate esterase stains. The histochemical stains were performed according to standard protocols. Chloracetate esterase staining was performed on all of the FOP (both lesional and nonlesional) specimens and all of the control nluscle samples. A Giemsa stain was also performed on all of the FOP tissue and 26 of the control muscle samples. The chloracetate esterase-stained specimens were used to score mast cells and for photographic purposes because of the ease of differentiation of mast cells with this stain. All slides were examined under light microscopy by 2 investigators (F.H.G. and L.D.R.T.). Each of the stained sections was examined at high magnification (40X), and mast cells were counted in 10 high-power fields. Five 
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RESULTS
Mast Cells in Normal Muscle
Representative muscle groups were examined from axial, appendicular, cranial, truncal, caudal, dorsal, ventral, proximal, and distal regions of the body (Table 1 ). There was a remarkably consistent distribution and low density of mast cells in normal skeletal muscle from all anatomic sites and across all age ranges. There were no differences in the pattern or density of mast cell distribution between uninvolved skeletal muscle from normal controls and uninvolved skeletal muscle from patients with FOP (Table 1) . Mast cells were limited in distribution to the connective tissue interstitium of normal skeletal muscle and uninvolved FOP muscle at a density of 50.1 mast cells per 10 high-power fields (Table 1) .
Mast Cells in Inflammatory Myopathies
Mast cell density in inflammatory myopathies ranged from 0.1 to 0.3 mast cells per 10 high-power fields, regardless of the underlying etiology of the myopathic process (Table 1) . Similar to normal skeletal muscle, the mast cells in inflammatory myopathies were limited to the interstitium in the majority of cases, with an occasional mast cell noted within the surrounding muscle.
Mast Cells in FOP Lesions
FOP lesions were staged histologically based on the pathologic and morphologic characteristics and have been designated lA, lB, lC, 2A, 2B, and 2C as previously described.The 1.4 lesion (Fig 1, panel la) is characterized by an intense perivascular B-cell and Tcell lymphocytic aggregation before invasion into the surrounding muscle tissue. Even at this early stage, mast cells are associated with perivascular lymphocytic infilhates and :we 10-fold more abundant (1.0 mast cells per 10 high-power fields) than in normal control skeletal muscle. In stage 1B lesiolls (Fig 1, panel lb) , T 1gmphocl;tes have migrated {I-om the perivascular space into the surrounding muscle. At this stage, mast cells are mobilized from the perisascular connecti~!e tissue interstitium of the dying skeletal muscle and are at a significantly higher concentratio11 than in normal control muscle tissue at any site in the body (Table 1) . Stage 1C lesio~ls are characterized by the first appearance of a vascular fibroproliferative tissue (Fig 1, panel  lc) that surrounds and invades the contiguous skeletal muscle. Mast cells are noted in abundance at this stage with a tissue density of 4 to 15 mast cells per 10 highpower fields, 40-to 150-fold greater than the density observed in normal skeletal muscle and nonlesional FOP muscle, and 10-to 4Wold greater than that obsenled in ally of the inflammatory myopathies ( Table 1 ) .
As an FOP lesion progresses into stage 2A (Fig 1,  panel 2a) , a highly monotonous vascular and edematous fibroproliferative lesion is noted. Mast cells are noted in abundance at the leading edge and around the periphery of the fibroproliferative lesion at a density indistinguishable from that of the 1C lesion. Stage 2B FOP lesions are identified by the first appearance of cartilage (Fig 1, panel 2b) , and the mast cells are generally confined to the fibrous pseudocapsule surrounding the cartilage. In stage 2C, the mature stage of the FOP lesion, endochondral ossification is noted (Fig 1,  panel 2c ). At this stage, mast cells are noted only at the periphery of the lesion at a density that is similar to that of the early stage 1A lesion (Table 1 ) but still 10-fold higher than in uninvolved skeletal muscle. However, at this stage, there is no longer any residual histologic presence of muscle; the previously existing skeletal muscle tissue has been replaced by bone.
DISCUSSION
The most significant finding of our study was the dramatic mobilization and activation of inflammatory mast cells at all stages of FOP lesional development. These data document an unanticipated and previously unrecognized presence of mast cells in the pathology of FOP lesions. Mast cells have long been known to be involved in bone'remodeling, but this is the first report to implicate their involvement in de novo osteogenesis?
Recent studies have elucidated conditions, such as disruption of the myofiber membrane, that induce mast cell accum~~lation in skeletal muscle.20 In an injured muscle, peak mast cell accumulation occurs at the onset of regeneration, approximately 3 days after experimental phospholipase injection or 11 days after ischemic injury, but not during the phase of muscle necrosis.'".-l' The pattern of mast cell infiltration in FOP lesions is qualitatively different from these findings and shows a steady progression of the mast cell numbers and associatio~l with myonecrosis and neoangiogenesis. The appearance of mast cells in FOP lesions is thus qualitatively different from that seen in a varieq of inflammato~? m~opathies and quantitatively much more intense.
Mast cells play a proini~le~lt role in the local invasion of tumors.~:~ Mast cells accumulate at the leading edge of invading carcinomas, where the? are conscripted for angiogenesis and local tumor invasion, but mast cells are not found in the core of the invading turn or^.^"^^ FOP, mast cells are found in abundance predominantly at the leading edge of the more mature FOP lesions (stages 2A to 2C;) and within the lesions themselves at the earlier, less mature stages (1A to 1C).
Mast cells discharge their stored granules into the interfascicular matrix of skeletal muscle upon exposure to a wide variety of immunologic or external stimula, including thermal or mechanical trauma and T cellmediated inflammatory proces~es.~"".~~ T cell-mast cell interactions are intimate, bidirectional, and robust.45-46 Mast cells are able to present antigens to T cells, and mast cell-derived cytokines such as interleukin 4 stimulate T cells to differentiate into various T-cell s~bsets.~6.4~ Conversely, T cell-derived mediators directly induce mast cell d e g r a n~l a t i o n .~6 -~~
The intimate temporal and spatial relationship of lymphocytes and mast cells in the FOP lesions lends additional support to the cooperative interaction of these hematopoietically derived cell types.
Our findings provide an intriguing model for the pathophysiology of FOP lesions that builds upon our earlier knowledge (Fig 2) . Cells in FOP are genetically conditioned toward a bone induction response, and lymphocytic infiltration of early FOP lesions has been observed. We hypothesize that tissue injury in FOP leads to lymphocyte migration into skeletal m u~c l e .~J~ Subsets of lesional lymphocytes overproduce BMP4 and lead to mast cell mobilization, a finding supported strongly by the FOP pathology and by models of bone morphogenetic protein-induced heterotopic ossificati0n~3~9 (Glaser et al, manuscript in preparation). Mediators released by degranulatiilg mast cells stimulate a re-entrant cycle of inflammatory edema, fibrosis, and angiogenesis potentiated at the leading edge of an advancing FOP lesion. Reactive fibroblasts produce stem cell factor, which leads to further proliferation of mast cells and a self-sustaining escalation of the disease process known as a flare-up. Eventually, TGF-/3 released by mast cells and other lesional cells modulates the l~mphocytic recruitment and migration, while endogenous overexpression of BMP4 in the fibroproliferative core drives the fibroproliferative lesion toward ossification through an endochondral pathway, regardless of the presence of mast cells (Fig 2) .
At present, no animal models of FOP mimic the flagrant tissue edema and the rapid spread of a preosseous fibroproliferative lesion along tissue planes. The presence of a normal skeleton in mast cell-deficient animals and the paucity of mast cells in experimental fracture healing suggest that mast cells are not necessary either for the embryonic formation and maturation of skeletal elelnents or for the repair of frat- 
